Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

Kathryn Elizabeth Bollinger; C. Medina; V. L. Perez

doi:10.1080/09273940802553287

Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

Kathryn Elizabeth Bollinger, C. Medina, V. L. Perez

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

Original language	English (US)
Pages (from-to)	23-25
Number of pages	3
Journal	Ocular Immunology and Inflammation
Volume	17
Issue number	1
DOIs	https://doi.org/10.1080/09273940802553287
State	Published - Feb 1 2009
Externally published	Yes

Keywords

Cutaneous leukocytoclastic vasculitis
Episcleritis
Ocular inflammation
Ocular manifestations vasculitis
Ocular vasculitis
Systemic vasculitis

ASJC Scopus subject areas

Immunology and Allergy
Ophthalmology

Access to Document

10.1080/09273940802553287

Cite this

@article{6c0da3c92136449e9b0f4888c2a549bf,

title = "Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis",

abstract = "Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.",

keywords = "Cutaneous leukocytoclastic vasculitis, Episcleritis, Ocular inflammation, Ocular manifestations vasculitis, Ocular vasculitis, Systemic vasculitis",

author = "Bollinger, {Kathryn Elizabeth} and C. Medina and Perez, {V. L.}",

year = "2009",

month = feb,

day = "1",

doi = "10.1080/09273940802553287",

language = "English (US)",

volume = "17",

pages = "23--25",

journal = "Ocular Immunology and Inflammation",

issn = "0927-3948",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

AU - Bollinger, Kathryn Elizabeth

AU - Medina, C.

AU - Perez, V. L.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

AB - Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

KW - Cutaneous leukocytoclastic vasculitis

KW - Episcleritis

KW - Ocular inflammation

KW - Ocular manifestations vasculitis

KW - Ocular vasculitis

KW - Systemic vasculitis

UR - http://www.scopus.com/inward/record.url?scp=67651236373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651236373&partnerID=8YFLogxK

U2 - 10.1080/09273940802553287

DO - 10.1080/09273940802553287

M3 - Article

C2 - 19294569

AN - SCOPUS:67651236373

SN - 0927-3948

VL - 17

SP - 23

EP - 25

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

IS - 1

ER -

Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this